Skip to main content Skip to navigation

Requirements for Category 1 Drug Precurors and Schedule 1 Controlled Drugs

Category 1 Drug Precursors and Schedule 1 Controlled Drugs are subject to strict controls to prevent their illicit use.

The University currently does not hold licences for research involving the use of Category 1 Drugs Precursors and Schedule 1 Controlled Drugs. Therefore currently no orders can placed for such materials and no work can be carried out involving their use.

The University is in the process of applying for new licences and this information will be updated accordingly. The process detailed below indicates the requirements for obtaining and using licenced materials

The Director of Health and Safety is the Responsible Person for the University for Controlled Drugs and Drug Precursors.

All transactions to purchase and/or destroy Category 1 Drug Precursors must be notified to the Director of Health and Safety on a Request to Purchase Form BEFORE the transaction takes place. The transaction must only proceed once the submission has been reviewed and approved and the relevant licence obtained.

Principal Investigators are responsible for ensuring that they and their research teams comply with this procedure.

As the Responsible Person for the University for Schedule 1 Drugs and Category 1 Drug Precursors the Director of Health and Safety will:
• Authorise each procurement
• Approve control and security measures in consultation with the Head of Security
• Witness each ultimate disposal
• Maintain a register of Category 1 Drug Precursors and Schedule 1 Controlled Drugs held at the University and the names of the Principal Investigator responsible for each.
• Audits these arrangements

Requirement prior to procurement of Category 1 Drug Precursors and Schedule 1 Controlled Drugs

Principal Investigators must submit a ‘Request to Purchase’ form to the Health and Safety Helpdesk with a copy to the Chair of the Departmental Health and Safety Committee:

• Providing justification for the use of the substance and specifying persons carrying out the research

• Specifying the control measures that will be implemented for use and storage

• Proposing the method of destruction within the experimental risk assessment


The Chair of the Departmental Health and Safety Committee in consultation with the Director of Health and Safety approves the proposal to bring the classified material into the Department.
When the proposal has been agreed and accepted, a Record of Use will be issued to the Principal Investigator who must maintain this document and ensure it is always available for review by the Health and Safety Department and by enforcement agencies.
The Principal Investigator is responsible for completing the Customer Declaration form from the supplier.

Holding and Use of Schedule 1 Drugs and Category 1 Drug Precursors

The Principal Investigator
• Takes physical charge of the material upon delivery to University
• Raises ‘record of use’ sheet and ensures all uses are recorded
• Signs of the records of usage for each bottle of classified material
• Regularly monitors that the quantity of material held is in agreement with the record sheet.


The specified authorised users must comply with this protocol and must record each use at the time of use on the Record of Use Form.
The Principal Investigator is responsible for ensuring that the Schedule 1 Drug / Category 1 Drugs Precursor and the Record of Use Form are kept secure and that the Record of Use Form is completed by the authorised users. The Record of Use Form must be made available to the Director of Health and Safety on demand and must be made available for inspection by enforcement agencies.

Final Disposal of Schedule 1 / Category 1 material

The destruction method must be proposed by the Principal Investigator and approved by the Responsible Person (Director of Health and Safety). The destruction of these materials must be witnessed by the Director of Health and Safety or other authorised Responsible Person.

The Principal Investigator ensures that a signed copy of the completed record sheet is sent to the Director of Health and Safety upon ultimate disposal.

Loss of Material

In the event of any theft or unexplained loss or other suspicious transactions being identified, the Director of Health and Safety and Head of Security must be notified immediately.

 Category 1 Drug Precursors   Substance CN Code
  • Ephedrine 2939 4100
  • Ergometrine 2939 6100
  • Ergotamine 2939 6200
  • Lysergic Acid 2939 6300
  • BMK (1-phenyl-2-propanone) 2914 3100
  • Piperonal 2932 9300
  • Pseudoephedrine 2939 4200
  • N-acetylanthranilic acid 2924 2300
  • PMK (3-4 methylenedioxy-phenylpropan-2-one) 2932 9200
  • Isosafrole 2932 9100
  • Safrole 2932 9400
  • Norephedrine 2939 4400
  • Alpha-phenylacetoacetonitirile (APAAN) 2926 90 95